Drug Avastin Not Associated with Higher Risk of Blindness: Study: THURSDAY.

Avastin is used to treat a variety of cancers. It’s also used to take care of wet age-related macular degeneration, a progressive disease of the optical eyesight that triggers loss of the capability to see straight ahead.. Drug Avastin Not Associated with Higher Risk of Blindness: Study: – THURSDAY, Aug. 13, 2015 – – Concerns that eye shots of the drug Avastin increase the risk of a possibly blinding eye infection may be unfounded, a new study finds. Researchers analyzed insurance statements data from over the USA to compare the usage of Avastin to treat retinal illnesses with a more expensive medication called Lucentis . The scholarly study was conducted in response to reports of Avastin-related eye infections that led the U.S. Food and Drug Administration to propose restricted restrictions on the usage of the drug for vision conditions.Overall, 26.5 percent of the patients in the ocriplasmin group reached the principal end point , as compared with 10.1 percent of these in the placebo group with Ocriplasmin versus Placebo to Day 180.). The between-group difference in the %age of eye with resolution of vitreomacular adhesion reached significance at day time 7, your day of the 1st study visit following the injection , and the %age remained higher with ocriplasmin at all subsequent visits through month 6 . The magnitude of the effect of ocriplasmin on the principal end point varied according to zoom lens status. Among phakic eye, 34.2 percent in the ocriplasmin group versus 12.6 percent in the placebo group got resolution of vitreomacular adhesion ; among eyes with pseudophakia, 13.4 percent in the ocriplasmin group versus 3.8 percent in the placebo group had resolution of vitreomacular adhesion .